Related Experiment Video

Updated: Aug 6, 2026

Intracranial Subarachnoidal Route of Infection for Investigating Roles of Streptococcus suis Biofilms in Meningitis in a Mouse Infection Model
07:26

Intracranial Subarachnoidal Route of Infection for Investigating Roles of Streptococcus suis Biofilms in Meningitis in a Mouse Infection Model

Published on: July 1, 2018

[Effects of anisodamine and ampicillin on cerebrospinal fluid in experimental E coli meningitis]

Y X Liu1

  • 1Department of Pediatrics, Affiliated Xiangya Hospital, Hunan Medical University, Changsha.

Zhonghua Yi Xue Za Zhi
|May 1, 1993
PubMed

Insights

Anisodamine combined with ampicillin effectively treats experimental E. coli meningitis in rabbits, reducing harmful biomarkers in cerebrospinal fluid (CSF) more than ampicillin alone.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Pharmacology

Context:

  • Bacterial meningitis, particularly E. coli meningitis, poses a significant threat, especially in neonates.
  • Cerebrospinal fluid (CSF) analysis reveals key biomarkers of infection and inflammation, including bacterial titer, endotoxin, malondialdehyde (MDA), lactate, and lactic dehydrogenase (LDH).
  • Current therapeutic strategies primarily rely on antibiotics, but adjunctive therapies are being explored to improve outcomes.

Purpose:

  • To evaluate the efficacy of anisodamine combined with ampicillin therapy in a rabbit model of experimental E. coli meningitis.
  • To assess the impact of this combination therapy on key CSF biomarkers compared to ampicillin monotherapy and untreated controls.

Summary:

  • In rabbits with experimental E. coli meningitis, CSF levels of bacterial titer, endotoxin, MDA, lactate, and LDH were significantly elevated.
  • Ampicillin therapy alone reduced bacterial titer but did not significantly alter other biomarkers.
  • Combined anisodamine and ampicillin therapy significantly reduced CSF endotoxin and lactate levels, and MDA concentration, outperforming ampicillin monotherapy.

Impact:

  • The findings suggest that anisodamine, when used as an adjunct to antibacterial treatment, offers superior efficacy in managing experimental E. coli meningitis.
  • This combination therapy may represent a promising strategy to mitigate inflammation and tissue damage associated with bacterial meningitis.
  • Further research could explore the clinical application of anisodamine in human meningitis cases.

More Related Videos

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

Amikacin Protection Assay for Quantification and Visualization of Escherichia coli Cell Invasion09:22

Amikacin Protection Assay for Quantification and Visualization of Escherichia coli Cell Invasion

Published on: July 3, 2026

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...